Overview
David Frucht is an Infectious Disease provider in Alexandria, Virginia. Dr. Frucht is rated as an Advanced provider by MediFind in the treatment of Anthrax Infection. His top area of expertise is Anthrax Infection.
His clinical research consists of co-authoring 17 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 8 articles in the study of Anthrax Infection.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Arthur Friedlander is an Infectious Disease provider in Frederick, Maryland. Dr. Friedlander is rated as an Advanced provider by MediFind in the treatment of Anthrax Infection. His top areas of expertise are Anthrax Infection and Melioidosis.
Robert Danner is an Infectious Disease specialist and an Intensive Care Medicine provider in Bethesda, Maryland. Dr. Danner is rated as a Distinguished provider by MediFind in the treatment of Anthrax Infection. His top areas of expertise are Sepsis, Toxic Shock Syndrome, Necrotizing Fasciitis, and Anthrax Infection.
Alan Cross is an Infectious Disease provider in Baltimore, Maryland. Dr. Cross is rated as an Advanced provider by MediFind in the treatment of Anthrax Infection. His top areas of expertise are Sepsis, Pseudomonas Stutzeri Infections, Anthrax Infection, and Pneumonia.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers